# Antenatal Magnesium Sulphate in High-Risk Preterm Patients

> **NCT07524972** · PHASE3 · RECRUITING · sponsor: **Cairo University** · enrollment: 138 (estimated)

## Conditions studied

- Cerebral Palsy
- Magnesium Sulfate Overdose

## Interventions

- **DRUG:** Magnesium sulfate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07524972
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-05-30
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07524972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07524972, "Antenatal Magnesium Sulphate in High-Risk Preterm Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07524972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*